Pharmacokinetics Module

Pharmacokinetics Module

Pharmacokinetics Module

FDA, EMA and AERS documents contain vast amounts of crucial data that never reach academic publications. The Pharmacokinetic Module allows you to search these data, which have been extracted from more than 1.6 million pages, including FDA Approval Packages (1992 to present) and EMEA EPARs (1995 to present). It also gives you the FDA Classic Collection, which dates back to 1938.


Contact Sales


Use the Pharmacokinetics Module to more effectively assess your drug candidates:

  • Model therapeutic windows for new drug projects more effectively
  • Assess different chemical substructures or active groups re: exposure properties
  • Compare internally generated exposure data with similar drugs
  • Make crucial risk assessments about the dose and delivery of drugs
  • Assess drug repurposing possibilities, even for older drugs

Pharmacokinetics Module




Consolidated data you won't easily find elsewhere

The Pharmacokinetics Module gives you a range of information that is not otherwise easy to find. This includes detailed exposure data (Cmax, Tmax, T1/2, AUC, etc.) that are almost never published and are not available in any other commercial database. You'll also find critical data on drug efficacy and results, and dosage, safety and pharmacokinetics studies.

Pharmacokinetics Module

One platform with access to both FDA and EMA documents

With the possibility to compare data extracted from 1.6 million pages of regulatory documentation, the Pharmacokinetics Module highlights the differences between the FDA and EMA decision-making processes. For example, the database contains information about over 50 drugs and active ingredients approved in Europe but not in the US. See the differences, improve your own regulatory submissions and benefit from competitive advantages on the global market.

More refined searching power

Search for key parameters and experimental conditions and apply filters to refine your results. You also have the option to sort your results under multiple conditions, including:

  • Drug name
  • Concomitant drugs
  • Dose or standard dosage
  • Route
  • Value (normalized in searching)
  • Disease states
  • Demographic differences
  • Study group (population)
  • Value (normalized in searching)
  • Enantiomers
  • Metabolites



Historical Context

Older FDA documents can give you an edge in the approval process and open up repurposing opportunities for older drugs. The Pharmacokinetics Module allows you to explore the whole history of drug development data in a single search. Find efficacy, safety and pharmacokinetics information from the FDA FOI archives dating back to 1938, and look at the available biology and chemistry data on older drugs to find new modeling data sets and repurposing opportunities.


Contact Sales